FDA Inspection 1219451 — Institute For Reproductive Medicine And Science At Saint Barnabas, P.A.
The FDA completed an inspection of Institute For Reproductive Medicine And Science At Saint Barnabas, P.A. on Sep 27, 2023 in Livingston, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Sep 27, 2023
- Fiscal Year
- 2023
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Livingston, NJ (United States)